Enzychem Lifesciences Announces Global Phase 2 Trial Inititation of EC-18 in Patients with Chemotherapy Induced Neutropenia(CIN)

Enzychem Lifesciences, Corp., a Korea based life sciences company announced the initiation of the dose-escalation stage ...

June 20, 2017 | Tuesday | News
NanoBio And Porton Biopharma receive approval to advance Anthrax Vaccine

NanoBio Corporation, a US based biopharmaceutical company focused on developing and commercializing vaccines and anti-in...

June 20, 2017 | Tuesday | News
New, long-acting insulin therapy demonstrates Cardiovascular Safety

Singapore - During a symposium, titled "Cardiovascular Safety of Insulin Degludec vs. Insulin Glargine in Patients with ...

June 13, 2017 | Tuesday | News
A translational research collaboration

The Scripps Research Institute (TSRI) and ShangPharma Innovation, Inc. (SPII) announced a strategic collaboration to acc...

June 9, 2017 | Friday | News
BD Receives FDA 510(K) Clearance for Molecular Test of Acute Gastroenteritis.

Singapore - BD (Becton, Dickinson and Company), a global medical technology company, announced 510 (k) clearance from th...

June 5, 2017 | Monday | News
Trends in Drug Discovery Outsourcing: A Perspective

Dr Subir Basak Chief Business Officer, GVK Biosciences Over the last two decades, the Pharmaceutical industry has seen ...

June 2, 2017 | Friday | Analysis
FDA approves new Novo Nordisk treatment for patients with Hemophilia

Singapore - Novo Nordisk, a US based global healthcare company announced that the U.S. Food and Drug Administration (FDA...

June 1, 2017 | Thursday | News
Biogen acquires Remedy Pharmaceuticals’ late stage drug CIRARA

Singapore: Remedy Pharmaceuticals, a privately-held pharmaceutical company focused on bringing life-saving treatments to...

May 23, 2017 | Tuesday | News
Symic Bio Secures $30 Million Series B financing 

Singapore: Symic Bio, a US based biopharmaceutical company announced the successful completion of a $30 million&nbs...

May 23, 2017 | Tuesday | News
Sanofi enters into a $273 mn research deal with Exscientia

Singapore: French drug giant Sanofi has inked a $273 million research deal and licence option agreement in metabolic dis...

May 10, 2017 | Wednesday | News
FDA approves first new drug for ALS in 2 decades

After nearly two decades FDA has finally approved a drug for the treatment of amyotrophic lateral sclerosis (ALS). The d...

May 11, 2017 | Thursday | News
A new drug for diabetes

Indian scientists have found that a plant-derived substance called chalcone can be used to make an effective anti-diabet...

May 2, 2017 | Tuesday | News
Foamix Pharmaceuticals Ltd. completed Phase 3 trials for FMX101

Foamix Pharmaceuticals Ltd., a clinical stage specialty pharmaceutical company focused on developing and commercializing...

May 2, 2017 | Tuesday | News
Novel antibiotic resistance gene found in milk

According to the new study conducted by researchers of the University of Bern in Switzerland 'harmless' bacteria found i...

May 1, 2017 | Monday | News
Glenmark initiates clinical investigation for respiratory drug

Global pharmaceutical major Glenmark Pharmaceuticals has received the US Food and Drug Administration (USFDA) approval f...

April 28, 2017 | Friday | News
Asceneuron gets regulatory approval to initiate clinical trial of new drug candidate

Singapore: Asceneuron, an emerging leader in the development of innovative small molecules for neurodegenerative disease...

April 7, 2017 | Friday | News
Licensing agreement announced for sutezolid drug for TB

TB Alliance and Medicines Patent Pool announced a licensing agreement for the clinical development of sutezolid. It is a...

March 24, 2017 | Friday | News
Astex Pharma cancer drug receives US marketing approval

Astex Pharmaceuticals, a pharmaceutical company dedicated to the discovery and development of novel small molecule thera...

March 14, 2017 | Tuesday | News